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ABSTRACT: The load phase in preparative Protein A capture
steps is commonly not controlled in real-time. The load volume
is generally based on an offline quantification of the monoclonal
antibody (mAb) prior to loading and on a conservative column
capacity determined by resin-life time studies. While this
results in a reduced productivity in batch mode, the bottleneck
of suitable real-time analytics has to be overcome in order to
enable continuous mAb purification. In this study, Partial Least
Squares Regression (PLS) modeling on UV/Vis absorption
spectra was applied to quantify mAb in the effluent of a Protein
A capture step during the load phase. A PLS model based on
several breakthrough curves with variable mAb titers in the
HCCF was successfully calibrated. The PLS model predicted the
mAb concentrations in the effluent of a validation experiment
with a root mean square error (RMSE) of 0.06 mg/mL. The
information was applied to automatically terminate the load
phase, when a product breakthrough of 1.5 mg/mL was reached.
In a second part of the study, the sensitivity of the method was
further increased by only considering small mAb concentrations
in the calibration and by subtracting an impurity background
signal. The resulting PLS model exhibited a RMSE of prediction
of 0.01 mg/mL and was successfully applied to terminate the
load phase, when a product breakthrough of 0.15 mg/mL was
achieved. The proposed method has hence potential for the real-
time monitoring and control of capture steps at large scale
production. This might enhance the resin capacity utilization,
eliminate time-consuming offline analytics, and contribute to
the realization of continuous processing.
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Introduction
A capture step is the first unit operation in the protein purification
process which is used to bind the target protein from crude
harvested cell culture fluid (HCCF). It increases product
concentration as well as purity and prevents proteolytic degrada-
tion. Due to its high selectivity, Protein A capture is widely used in
current monoclonal antibody (mAb) purification platform pro-
cesses (Hahn et al., 2006; Shukla et al., 2007; Shukla and Th€ommes,
2010; Tarrant et al., 2012; Tsukamoto et al., 2014).
A difficulty in Protein A capture is a lack of real-time analytics for
mAb quantification in the HCCF and in the column effluent during
loading. Since both the mAb and impurities contribute to the
absorption at 280 nm (A280), single wavelength measurements are
not suitable as selective analytics (Gupta, 2002). To determine the
mAb titer in the HCCF, elaborate offline analytics is commonly
performed (Fahrner and Blank, 1999b). As mAb titers are
influenced by variability in the cell culture, this offline analytics
has to be repeated for every lot in order to adapt the load volume
onto the column (Fahrner and Blank, 1999a). While this results in a
reduced productivity in batch mode, the bottleneck of suitable real-
time analytics has to be overcome to enable continuous mAb
purification.
In addition to themAb titer in the HCCF, the optimal load volume
onto the column is also influenced by the resin capacity. Due to
leaching and degradation of the Protein A ligands as well as pore
and ligand blocking by leftover impurities or product, the capacity
of the resin decreases over cylce time (Jiang et al., 2009). In batch
mode, a conservative loading is commonly applied to avoid
breakthrough of the expensive product at the cost of productivity. In
contrast to that, columns are overloaded in continuous mode to
maximize productivity (Angarita et al., 2015). In this case, the
determination of the the percentual product breakthrough is
necessary for process control (Warikoo et al., 2012).
To perform (near) real-time process monitoring and control,
several process analytical technology (PAT) tools have been
developed to enable fast mAb quantification in the cell culture fluid
and in the column effluent during loading. For instance, atline
mid-IR spectroscopy in combinationwith multivariate data analysis
has been applied for secreted mAb quantification during a Chinese
Hamster Ovary (CHO) cell culture process (Capito et al., 2015).
Selective mAb quantification in upstream processing was also
successfully realized by atline matrix-assisted laser desorption/
ionization mass spectrometry (Steinhoff et al., 2016). For the
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control of the load phase of a two column continuous Protein A
chromatography process, which was connected to a CHO perfusion
culture, atline analytical chromatography was applied (Karst et al.,
2015). Atline monitoring however, bears the risk of human errors
resulting in contamination, time-delays, or missing data.
In order to minimize human impact, automated sampling can be
applied. Automated analytical chromatography has been used in
upstream processing to monitor the mAb titers (Chase, 1986; Ozturk
et al., 1995; Paliwal et al., 1993). In downstream processing, this
technique was successfully used for mAb quantification in the column
effluent during the load phase of Protein Achromatography. As soon as
1%mAb breakthroughwas detected, the load phase was automatically
terminated (Fahrner and Blank, 1999a). Automated analytical
chromatography is relatively easy to develop and equipment is
commercially available. However, the equipment is expensive and the
technique error-prone. Besides from the risk of contamination, the
timedelay between sampling and analytical results bears the riskof late
reaction or requires a slow-down of the process.
PAT tools that operate in real-time, such as UV-based methods,
overcome these limitations. In a patent application, a UV-based
control method for determining binding capacities in Protein A
capture was disclosed (Patent WO2010151214A1, also described in
Warikoo et al., 2012). The method is based on the calculation of a
difference signal between two detectors situated at the column in-
and outlet. During the load phase, the post-column signal is
supposed to stabilize and is referred to as impurity baseline. As
soon as the mAb breaks through, there is an increase in the post-
column UV signal above the impurity baseline which corresponds
to a breakthrough level of the product. Consequently, the method is
very suitable for determining column switching times in continuous
Protein A capture. It allows for an equal loading in terms of
percentual breakthrough regardless of the mAb titer variability in
the feed or decreasing column capacities. However, it requires two
detectors posing a risk of unequal detector drifts. A further
limitation might be displacement effects of contaminants that
prevent a stabilized impurity baseline. The technique might also be
limited to the equipment of the future patent holder.
Another recently published UV/Vis-based method for monitor-
ing and control in protein chromatography applies UV/Vis
absorption spectra instead of single wavelength measurements
(Brestrich et al., 2014, 2015). Different protein species exhibit
distinct variations in their UV absorption spectra. Consequently,
Partial Least Squares Regression (PLS) technique has been used to
correlate absorption spectra with selective protein concentrations.
The method was successfully applied for a selective inline protein
quantification and for product purity-based pooling decisions in
real-time. However, no load control in Protein A chromatography
has been performed so far using this technique.
In this study, PLS models correlating UV/Vis absorption spectra
with mAb concentrations were applied for real-timemonitoring and
control of the load phase in Protein A chromatography. In contrast
to previous publications in this field, this application requires the
monitoring of one protein in the background of many protein and
non protein-based contaminants. For the PLS model calibration,
several breakthrough experiments were performed and the
corresponding absorption spectra of the effluent were acquired.
In order to generate variable mixing ratios of mAb and
contaminants for a PLS model training data set, experiments
with variable mAb titers in the feed were performed. The column
effluent was collected in fractions and analyzed using analytical
Protein A chromatography. The recorded absorption spectra were
averaged according to the fraction time and correlated with the
determined mAb concentrations using PLS technique. The PLS
model was eventually applied for a real-time control of the load
phase and terminated loading, when 5% or 50% product
breakthrough was reached.
Materials and Methods
Cell Culture Fluid and Buffers
HCCF and mock were obtained from Lek Pharmaceuticals d.d.
(Menges, Slovenia) and stored at 80C before experimentation.
The HCCF and mock were filtered with a cellulose acetate filter with
a pore size of 0.22mm (Pall, Port Washington, NY) before use. In
order to achieve a variable mAb concentration in the feed, the HCCF
was diluted with mock.
For all preparative runs, the following buffers were applied:
Equilibration with 25mM tris and 0.1M sodium chloride at pH 7.4,
wash with 1M tris and 0.5M potassium chloride at pH 7.4, elution
with 20mM citric acid at pH 3.6, sanitization with 50mM sodium
hydroxide and 1M sodium chloride, and storage with 10mM
sodium phosphate, 130mM sodium chloride, 20% ethanol.
For analytical Protein A chromatography, column equilibration
was carried out using a buffer with 10mM phosphate (from sodium
phosphate and potassium phosphate) with 0.65M sodium ions
(from sodium chloride and potassium chloride) at pH 7.1. Elution
was performed with the same buffer, but titrated to pH 2.6 with
hydrochloric acid. All buffer components were purchased from
VWR,West Chester, USA. The buffers were prepared with Ultrapure
Water (PURELAB Ultra, ELGA LabWater, Viola Water Technologies,
Saint-Maurice, France), filtrated with a cellulose acetate filter with a
pore size of 0.22mm (Pall), and degassed by sonification.
Chromatographic Instrumentation
All preparative runs were realized with an Akta Pure 25 purification
system controlled with Unicorn 6.4.1 (GE Healthcare, Chalfont
St Giles, UK). The system was equipped with a sample pump S9, a
fraction collector F9-C, a column valve kit (V9-C, for up to
5 columns), a UV-monitor U9-M (2mm pathlength), a conductivity
monitor C9, and an I/O-box E9. Additionally, an UltiMate 3000
diode array detector (DAD) equipped with a semi-preparative flow
cell (0.4 mm optical pathlength) and operated with Chromeleon 6.8
(Thermo Fisher Scientific, Waltham, MA) was connected to the
Akta Pure. The DAD was positioned between the conductivity
monitor and the fraction collector.
The communication between Unicorn and Chromeleon was
implemented analogous to the protocol published in (Brestrich
et al., 2014). Shortly, Unicorn triggers the DAD data acquisition by
sending a digital signal to a Matlab script (MathWorks, Natick,
MA), which communicates with Chromeleon via a Visual Basics for
Application Macro (Microsoft, Redmond, WA). If a certain
condition such as a defined mAb concentration is fulfilled, the
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Matlab script sends a signal back to Unicorn to terminate a phase in
the chromatographic method.
References analysis of collected fractions was performed using a
Dionex UltiMate 3000 rapid separation liquid chromatography
system (Thermo Fisher Scientific). The system was composed
of a HPG-3400RS pump, a WPS-3000 analytical autosampler, a
TCC-3000RS column thermostat, and a DAD3000RS detector.
Chromatography Runs
In order to generate variable mixtures between mAb and impurities
for the PLS model calibration and validation, breakthrough
experiments with variable mAb titers in the feed were performed.
The mAb titers in the different experiments were 2.7, 2.85, 3, 3.15,
and 3.3 mg/mL. For each experiment, a Sartobind 2mL Protein A
membrane (Sartorius, G€ottingen, Germany) was first equilibrated
for three membrane volumes (MVs) and then loaded with 33.15mg
mAb. At the beginning of the load phase, the DAD was triggered to
record absorption spectra between 200 and 410 nm and the
membrane flow-through was collected in 200mL fractions. After
a first wash with equilibration buffer for 4.5 MVs, the membrane
was flushed with wash buffer for 5.5 MVs and with equilibration
buffer for 4.5 MVs. Elution was carried out for 5MVs followed by a
re-equilibration of 1.5 MVs. Eventually, the column was sanitized
for 5MVs, and between the runs, kept in the storage buffer. The
flow rate was 1mL/min for all phases and experiments.
Analytical Chromatography
As displayed in Figure 1, the collected fractions of all runs were
examined by analytical Protein A chromatography to obtain the mAb
concentrations. For each sample, a 2.1 30mm POROS prepacked
Protein A column (Thermo Fisher Scientific, Foster City, CA) was
equilibrated with 2.6 column volumes (CVs) of equilibration buffer,
flowed by an injection of 20mL sample. The column was then
equilibrated with 0.8 CVs of equilibration buffer and eluted with
1.4 CVs of elution buffer. The flow rate was 2mL/min for all phases
and experiments.
Data Analysis
For the correlation of the absorption spectra with the mAb
concentrations, PLS technique was applied using SIMCA (MKS
Data Analytics Solutions, Umeå, Sweden). SIMCA applies the NIPALS-
algorithm for PLS. Before performing PLS, all spectra were
preprocessed by mean centering using SIMCA. PLS finds variation
in the spectral datamatrix, which is relevant for the correlationwith the
mAb concentrations, and thereby, separates information in the matrix
from detector noise (Eriksson et al., 2006; H€oskuldsson, 1988;Martens
and Næs, 1989). In order to achieve this separation, collinearity in the
data are reduced by summarizing variables (here wavelengths) with
similar information in latent variables (LVs). This is done in away such
that the content of relevant information for the correlation included in
each LV is highest for the first LVand decreases for the following ones.
The number of applied LVs in a PLS model is hence a measure of data
reduction and only a few LVs are required to obtain the correlation
between absorption spectra and mAb concentrations.
The number of applied LVs has to be evaluated thoroughly to
avoid under- or overfitting of a model. In order to determine a
reasonable number of LVs, the root mean square error (RMSE) for
the prediction of validation samples is usually determined in
dependence on the number of LVs applied in a PLS model. The
minimum corresponds to the optimal number of LVs. In this study,
cross validation was performed to determine an optimal number of
LVs. Therefore, the calibration data were separated into seven
groups. One group was then excluded during model calibration and
the RMSE for theses samples was calculated subsequently. For every
number of LVs, this procedure was performed until each group was
excluded. Based on the so obtained number of LVs, completely
independent runs were predicted to evaluate the final models.
A first PLS model calibration was based on the results of the
runs with the following mAb titers in the feed: 2.7, 2.85, 3.15, and
3.3 mg/mL. The results of the corresponding spectral acquisitions
are time, wavelength, and absorption 3D-fields. The 3D-fields
were averaged in time according to the fraction duration as
displayed in Figure 1. The results of theses calculations were
stored in an absorption matrix. Afterward, PLS was carried out to
correlate the mAb concentrations of the collected fractions with
the the corresponding absorption matrix.
For lower protein concentrations, a second PLS model was
calibrated. Only samples with mAb concentrations below 0.5mg/mL
were considered in the model calibration. For those samples, a
background subtraction was performed. As soon as the change in
absorption signal after impurity breakthrough fell under a predefined
threshold, an average absorptionwas calculated for everywavelength.
This impurity background was subtracted from the absorption of all
following data points.
Real-Time Monitoring and Control
The first calibrated PLS model was subsequently applied for a real-
time monitoring of the mAb concentrations in a run with a mAb
titer of 3mg/mL in the feed. While the calibration of the PLS model
was performed using averaged spectra, predictions were based on
the 3D-fields. This means that the a spectrum at each time point
was applied to predict the mAb concentrations. The absorption
spectra of the effluent were recorded and translated into mAb
concentrations in real-time by the calibrated PLS model. The
calculation of the mAb concentrations was executed in Matlab. In a
first run, a stop criterion of 1.5mg/mL mAb concentration (50%
product breakthrough) was set in the Matlab evaluation script. As
soon as the termination criterion was reached, a digital signal was
send fromMatlab to Unicorn and the load phase was terminated. In
a second run, the stop criterion to terminate the load phase was set
to a target concentration of 0.15mg/mL (5% product break-
through). For this condition, the second PLS model was used.
Results and Discussion
The setup described in the Section Material and Methods was used
to monitor the breakthrough of mAb with UV/Vis spectroscopy in
combination with PLS modeling. To calibrate the PLS model, four
chromatographic runs at mAb concentrations of 2.7, 2.85, 3.15, and
3.3 mg/mL in the feed were performed and analyzed by offline
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analytics. The model was eventually confirmed by performing a
real-time control of two runs with a mAb titer of 3 mg/mL. The
difference in the mAb titers in the feed ensured variable mixing
ratios between product and contaminants. This was done to imitate
variability in upstream processing and to span a calibrated design
space for the PLS model.
PLS Model Calibration
The results of the model calibration are illustrated by Figure 2. It
compares the A280 (recorded at a pathlength of 0.4 mm and
displayed as dashed black line) to the concentrations measured by
offline analytics (blue bars) and the signal calculated by the
calibrated PLSmodel (solid red lines). The number of LVs was set to
four based on a minimal RMSE of 0.08mg/mL in the cross
validation. The calibrated PLS model was applied to evaluate all
3D-fields. In contrast to model calibration, where averaged spectra
were used, the spectral raw data at each time point was translated
into concentrations. The estimated concentrations by the PLS
model closely follow the measured values by offline analytics. It is
worth noting that no clear plateau of the A280 is reached after the
breakthrough of media components. Instead, the A280 continuous to
increase. This may be caused by different impurities being retained
differently on the membrane. Indeed, it has previously been shown,
that major interactions between HCPs, the stationary phase, and
mAbs may occure (Aboulaich et al., 2014; Shukla and Hinckley,
2008). The advent of mAb breakthrough cannot be clearly
distinguished from A280 alone. Based on the multivariate spectral
data, the PLS model is able to predict protein concentrations, which
allows for real-time monitoring and control.
Real-Time Monitoring and Control
For the confirmation of the obtained results, the calibrated PLS model
was used to control the load phase of a Protein A capture step in real-
time. In a first run, a target breakthrough concentration of 1.5mg/mL
was set, which corresponds to 50% product breakthrough.
Figure 3A shows the A280 (dashed black line), the real-time prediction
of mAb concentrations (solid red line) and the corresponding offline
analytics (blue bars). The model reached an RMSE for prediction of
0.06mg/mL compared to the offline analytics. This approachmay be of
interest for controlling a continuous chromatography system. In this
context, the prediction of lower mAb concentrations is not so crucial.
For a possible application in batch chromatography, the sensitivity
of the model was further improved. A second PLS model was hence
Figure 1. Experimental procedure for the PLSmodel calibration: For each calibration run, 200 mL fractions were collected and analyzed by analytical Protein A chromatography
to obtain the mAb breakthrough curves. In addition, averaged spectra corresponding to the fraction size were calculated from the time, wavelength, and absorption 3D-field.
Averaged spectra and mAb concentrations were eventually correlated using PLS technique.
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calibrated based on the calibration data set as described in the
method section. The recalibration was performed to increase the
sensitivity in the given concentration range. It was noticed, that it is
difficult to accurately calibrate a PLS model for broad concentration
ranges. By reducing the concentration calibration range, smaller
RMSEvalues could be achieved. Themodelwas used predict and stop
a loadphase in a second run at 0.15mg/mL,which corresponds to 5%
product breakthrough. The results of this second run are displayed in
Figure 3B. As an impurity background was subtracted to increase the
sensitivity of the method, the A280 suddenly decreases. The second
PLS model reached an RMSE for prediction of 0.01mg/mL.
During both runs, the respective load phases were successfully
terminated close to the intended breakpoints. In Table I, a summary of
intended andmeasuredmAb concentrations in the last fraction of both
confirmation runs is shown. The Matlab script sent a digital signal to
Unicorn and terminated the load phase, when the targeted
breakthrough concentrationwas reached. As the targeted breakthrough
set pointswere concentrations at discrete time points, they are expected
Figure 2. Results of the PLS model calibration. The A280 (measured at a pathlength of 0.4 mm and displayed as dashed black line) is compared with the results of the offline
analytics for mAb quantification (blue bars). The PLS model prediction is illustrated as red lines. The four runs exhibited variable mAb titers in the feed A: 3.3 mg/mL, B: 3.15 mg/mL,
C: 2.85 mg/mL, D: 2.7 mg/mL.
Figure 3. Results of the model evaluation by performing a real-time control of the load phase using a mAb titer of 3 mg/mL in the feed. The PLS model prediction (red lines) is
compared with the results of the offline analytics (blue bars) as well as the A280 (measured at a pathlength of 0.4 mm and displayed as dashed black line). The load phase was
automatically terminated, when a mAb concentration in the effluent of A: 1.5 mg/mL or B: 0.15 mg/mL was reached. The sudden decrease in the A280 arises from the background
subtraction.
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to be slightly higher than the concentrations of the last fraction
determined by offline analytics. This was observed for both
confirmation runs (cf. Table I). For an easier comparison between
model and offline analytics, a concentration based on an averaged
absorption spectrum was calculated for the last fractions of both runs
and compared with the corresponding offline analytics. For the first
run, the deviation between prediction and reference was 8.0%, while
for the second run a deviation of 2.3% was found. This demonstrates
that the described method can be successfully used to control the load
phase in a Protein A capture step.
Conclusion and Outlook
A real-time monitoring and control of the load phase in a Protein A
capture step was successfully realized in this study. It was
demonstrated that PLS modeling on UV/Vis absorption spectra can
be applied to quantify mAb in the effluent during the load phase
despite of the background of many protein and non protein-based
impurities. Based on the quantification, the load phase was
automatically terminated, when a product breakthrough concen-
tration of 1.5 mg/mL or 0.15mg/mLwas reached. Consequently, the
proposed method has potential for the monitoring and control of
capture steps at large scale production. In batch chromatography,
the loading volume may be defined dynamically to allow for
increased resin capacity utilization while still keeping the product
loss small. Additionally, time-consuming offline determination of
the mAb titer in HCCF could be eliminated. The methodmay also be
interesting for controlling column switching times in continuous
chromatographic capture steps. Future challenges are especially
related to the scale up and robustness of the method. Regarding the
latter, especially upstream variations should be calibrated into the
PLSmodel. Research will now focus on the migration of the method
to the control of continuous capture steps.
This project has received funding from the European Union’s Horizon 2020
Research and Innovation Programme under grant agreement No 635557. We
kindly thank Lek Pharmaceuticals d.d. (Menges, Slovenia) for providing the
HCCF and mock. This article is related to a patent application filed at the
Euorpean Patent Office under the number EP15196599.3.
References
Aboulaich N, Chung WK, Thompson JH, Larkin C, Robbins D, Zhu M. 2014. A novel
approach to monitor clearance of host cell proteins associated with monoclonal
anti-bodies. Biotechnol Prog 30:1114–1124.
Angarita M, M€uller-Sp€ath T, Baur D, Lievrouw R, Lissens G, Morbidelli M. 2015.
Twin-column capture SMB: A novel cyclic process for protein A affinity
chromatography. J Chromatogr A 1389:85–95.
Brestrich N, Briskot T, Osberghaus A, Hubbuch J. 2014. A tool for selective inline
quantification of co-eluting proteins in chromatography using spectral
analysis and partial least squares regression. Biotechnol Bioeng
111:1365–1373.
Brestrich N, Sanden A, Kraft A, McCann K, Bertolini J, Hubbuch J. 2015. Advances
in inline quantification of co-eluting proteins in chromatography: Process-
data-based model calibration and application towards real-life separation
issues. Biotechnol Bioeng 112:1406–1416.
Capito F, Zimmer A, Skudas R. 2015. Mid-infrared spectroscopy-based
analysis of mammalian cell culture parameters. Biotechnol Prog
31:578–584.
Chase HA. 1986. Rapid chromatographic monitoring of bioprocesses. Biosensors
2:269–286.
Eriksson L, Johansson E, Kettaneh-Wold N, Trygg J, Wikstr€om C, Wold S. 2006.
Multi-and megavariate data analysis. Umeå: Umetrics Academy. p 95.
Fahrner RL, Blank GS. 1999a. Real-time control of antibody loading during
protein A affinity chromatography using an on-line assay. J Chromatogr A
849:191–196.
Fahrner RL, Blank GS. 1999b. Real-time monitoring of recombinant antibody break-
through during protein A affinity chromatography. Biotechnol Appl Biochem
29:109–112.
Gupta M. editor. 2002. Methods for affinity-based separations of enzymes and
proteins. Basel, Switzerland: Birkh€auser Basel.
Hahn R, Shimahara K, Steindl F, Jungbauer A. 2006. Comparison of protein A affinity
sorbents III. Life time study. J Chromatogr A 1102:224–231.
H€oskuldsson A. 1988. PLS regression methods. J Chemom 2:211–228.
Jiang C, Liu J, Rubacha M, Shukla AA. 2009. A mechanistic study of protein A chro-
matography resin lifetime. J Chromatogr A 1216:5849–5855.
Karst D, Steinebach F, Morbidelli M. 2015. Integrated continuous processing for
themanufacture of monoclonal antibodies, presented at Integrated Continuous
Biomanufacturing II, Berkeley CA, USA.
Martens H, Næs T. 1989. Multivariate calibration. Chichester, UK: John Wiley &
Sons.
Ozturk SS, Thrift JC, Blackie JD, Naveh D. 1995. Real-time monitoring of protein
secretion in mammalian cell fermentation: Measurement of monoclonal
antibodies using a computer-controlled hplc system (biocad/rpm).
Biotechnol Bioeng 48:201–206.
Paliwal S, Nadler T, Wang D, Regnier F. 1993. Automated process monitoring of mon-
oclonal antibody production. Anal Chem 65:3363–3367.
Shukla AA, Hinckley P. 2008. Host cell protein clearance during protein A
chromatography: Development of an improved column wash step.
Biotechnol Prog 24:1115–1121.
Shukla AA, Hubbard B, Tressel T, Guhan S, Low D. 2007. Downstream processing of
monoclonal antibodies–Application of platform approaches. J Chromatogr B
848:28–39.
Shukla AA, Th€ommes J. 2010. Recent advances in large-scale production of
monoclonal antibodies and related proteins. Trends Biotechnol 28:253–261.
Steinhoff RF, Karst DJ, Steinebach F, Kopp MR, Schmidt GW, Stettler A, Krismer J,
Soos M, Pabst M, Hierlemann A, Morbidelli M, Zenobi R. 2016. Microarray-
based MALDI-TOF mass spectrometry enables monitoring of monoclonal
antibody production in batch and perfusion cell cultures. Methods
104:33–40.
Tarrant RDR, Velez-Suberbie ML, Tait AS, Smales CM, Bracewell DG. 2012. Host cell
protein adsorption characteristics during protein A chromatography.–>
Biotechnol Prog 28:1037–1044.
Tsukamoto M, Watanabe H, Ooishi A, Honda S. 2014. Engineered protein A ligands,
derived from a histidine-scanning library, facilitate the affinity purification of
IgG under mild acidic conditions. J Biol Eng 8:1–9.
Warikoo V, Godawat R, Brower K, Jain S, Cummings D, Simons E, Johnson T, Walther
J, Yu M, Wright B, McLarty J, Karey KP, Hwang C, Zhou W, Riske F, Konstanti-
nov K. 2012. Integrated continuous production of recombinant therapeutic
proteins. Biotechnol Bioeng 109:3018–3029.
Table I. Results of both confirmation runs: The targeted concentration
to terminate loading is compared with the mAb concentration in the last
fraction as determined by offline analytics. PLS model prediction for the
last fraction based on an averaged absorption spectrum is shown for
comparison.
ctarget [mg/mL] canalytics [mg/mL] cmean, PLS [mg/mL]
1.50 1.36 1.47
0.150 0.129 0.126
R€udt et al.: Real-Time Monitoring of A Capture Step 373
Biotechnology and Bioengineering
